News and Trends 15 Mar 2023
Nanite receives funding to deliver genetic therapies to the lungs
Nanite Inc. has announced an investment from the Cystic Fibrosis Foundation of up to $2 million to develop gene delivery…
Drug delivery
- Latest Posts
News and Trends 9 Mar 2023
Ampersand Biomedicines launched to develop drugs that only work at disease sites
Flagship Pioneering has created Ampersand Biomedicines, a company creating programmable medicines that are intended to be safer, more tolerable, and…
News and Trends 2 Mar 2023
New lipid nanoparticle CRISPR delivery system developed
Lipid nanoparticles have been used to encapsulate CRISPR-Cas9 and deliver it to cells in mice, where it was highly effective…
News and Trends 21 Feb 2023
HKUMed develops nanoparticle-based targeted drug delivery system
A research team from LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has developed thyroid hormone (TH) -…
ADVERTISEMENT
News and Trends 2 Feb 2023
Recurv Pharma receives funding for cancer therapy development
Recurv Pharma Inc. is receiving up to $24 million in funding from TVM Capital Life Science through its TVM Life…
News and Trends 31 Jan 2023
Sensorion and EVEON collaborating on injection system to deliver gene therapy inner ear treatments
Sensorion and EVEON are collaborating on the design and development of an injection system for the delivery of Sensorion’s gen…
News and Trends 11 Jan 2023
New nanotransporter delivers drugs inside cells
A new study by the University of Barcelona in Spain has analyzed the viability of a new nanomolecule that can…
News and Trends 23 Dec 2022
InSitu Biologics and Mayo Clinic to co-develop anti-cancer therapeutics
InSitu Biologics, Inc. has entered into an agreement with the Mayo Foundation for Medical Education and Research to further develop…
More News! 21 Dec 2022
Watch: Aphaia Pharma interview
Aphaia Pharma is a Zug, Switzerland, headquartered clinical-stage biopharmaceutical company. It harnesses proprietary precision-targeted drug delivery technology to restore endogenous…
News and Trends 14 Dec 2022
Navigating running a startup as a Gen Z female founder
By: Alina Su, CEO and founder of NovaXS Biotech Corp The next generation of biotech founders are facing new challenges.…
ADVERTISEMENT
News and Trends 29 Nov 2022
Biocomposites antibiotic carrier, STIMULAN, receives approval for use in Mexico
UK-based medical devices company, Biocomposites Ltd., has announced that antibiotic carrier STIMULAN has received a new broad-based approval for use…
News and Trends 23 Nov 2022
Funding to develop wearable patch for type 2 diabetes
A project to develop a patch worn on the cheek that delivers peptide treatments for type 2 diabetes has been…
More News! 18 Nov 2022
Triastek cleared for 3D printed medicine treatment of ulcerative colitis
Triastek, Inc. has received clearance for its Investigational New Drug (IND) application from the United States Food and Drug Administration…
News and Trends 10 Nov 2022
Researchers develop new nanoparticle to deliver drugs direct to macrophages
How can a drug be delivered exactly where it is needed, while limiting the risk of side effects? The use…
News and Trends 8 Nov 2022
Study shows enhanced drug delivery to the brain
In a study recently published in the journal Nature Biomedical Engineering, Japanese researchers used a method called “lasso-grafting” to design…
News and Trends 2 Nov 2022
Could DNA nanotransporters treat cancer?
A team of Canadian researchers from Université de Montréal has designed and validated a new class of drug transporters made…
ADVERTISEMENT
News and Trends 31 Oct 2022
Researchers develop efficient nanovaccine delivery system boosting cellular immunity
A research group has successfully developed a new nanovaccine delivery system, to strongly activate cellular immunity, using one-tenth of the…
News and Trends 12 Sep 2022
SiSaf reveals positive preclinical data in siRNA program to treat osteopetrosis
SiSaf Ltd, an RNA delivery and therapeutics company, has announced positive data confirming safety and efficacy of its Bio-Courier next…
News and Trends 4 Oct 2021
Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain
Although most gene therapy still relies on non-infectious viral vectors for delivery, a recent venture financing round for the Swiss…
In Depth 15 Sep 2021
Blood Cells: The Future of Drug Delivery
From red blood cells to platelets, the cells in our own blood could prove an effective way of delivering drugs…